News24 | Lenacapavir: What it would it take to get the 6-monthly anti-HIV jab to SA

Speed, scale and price. That’s what would sway whether the drugmaker Gilead’s twice-a-year anti-HIV jab, lenacapavir, will be able to markedly slow down the world’s - and South Africa’s - new infections.